From the NLST randomized trial to the clinic: How should we implement individual lung cancer screening in clinical practice?;Vers un dépistage individuel du cancer broncho-pulmonaire en France? L'avis de l'IFCT, de la SIT et du GOLF

Revue des Maladies Respiratoires

Volumn 30, Issue 1, 2013, Pages 15-17

  Couraud, S ^a,b   Barlési, Fabrice ^c,g   Lemarie E ^d   Zalcman, G ^e   Milleron, B ^f   Assouad, Jalal ^g   Asquier, Elizabeth ^g   Besse, Benjamin ^g   Bouchet, Laurent ^g   Castelnau, Olivier ^g   Cortot, Alexis ^g   Couraud, Sébastien ^g   Debieuvre, Didier ^g   Falcoz, Pierre Emmanuel ^g   Ferretti, Gilbert ^g   Fournel, Pierre ^g   Frappé, Paul ^g   Garnon, Julien ^g   Girard, Nicolas ^g   Gounant, Valérie ^g   Guittet, Lydia ^g   Greillier, Laurent ^g   Khalil, Antoine ^g   Lefebure, Patricia ^g   Laurent, François ^g   Lemarié, Etienne ^g   Liebart, Sandra ^g   Margery, Jacques ^g   Mennecier, Bertrand ^g   Milleron, Bernard ^g   Molinier, Olivier ^g   Mouroux, Jérôme ^g   Pujol, Jean Louis ^g   Quoix, Elisabeth ^g   Revel, Marie Pierre ^g   Souquet, Pierre Jean ^g   Stach, Bruno ^g   Thomas, Pascal ^g   Trédaniel, Jean ^g   Westeel, Virginie ^g   Zalcman, Gérard ^g   more..

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d Université Franaois Rabelais   (France)

^e CAEN UNIVERSITY HOSPITAL   (France)

^f Intergroupe Francophone de Cancérologie Thoracique   (France)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CLINICAL PRACTICE; LUNG CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84878138924     PISSN: 07618425     EISSN: 17762588     Source Type: Journal    
DOI: 10.1016/j.rmr.2012.10.021     Document Type: Editorial

References (11)

1. The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Eng J Med 2011;365:395-409
2. National Lung Screening Trial Research Team. The national lung screening trial: Overview and study design. Radiology 2010;258:243-53
3. Wood DE, Eapen GA, Ettinger DS, et al. Lung cancer screening. J Natl Compr Canc Netw 2012;10:240-65
4. Mirkin JN. Benefits and harms of CT screening for lung cancer: A systematic review. JAMA 2012;20:1
5. Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: The prostate, lung, colorectal, and ovarian (plco) randomized trial. JAMA 2011;306:1865-73
6. Aberle DR, Adams AM, Berg CD, et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010;102:1771-9
7. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9
8. Kong CY, Lee JM, McMahon PM, et al. Using radiation risk models in cancer screening simulations: Important assumptions and effects on outcome projections. Radiology 2012;262:977-84
9. Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: Status after five annual screening rounds with low-dose CT. Thorax 2012;67:296-301
10. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012;21:308-15
11. Couraud S, Cortot AB, Greillier L, et al. From randomized trials to the clinic: Is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French 5 experts on behalfof the french intergroup (IFCT) and the groupe d'oncologie de langue française (GOLF). Ann Oncol 2012, doi:10.1093/annonc/mds476